tetano
Editor, Senior Moderator
Cureus
. 2022 Feb 26;14(2):e22637.
doi: 10.7759/cureus.22637. eCollection 2022 Feb.
Rare Thrombotic Complications of COVID-19: A Case Series
Sruthi Vellanki[SUP] 1 [/SUP], Anup Kumar Trikannad Ashwini Kumar[SUP] 1 [/SUP], Ryan Stoffel[SUP] 2 [/SUP], Sravya Vellanki[SUP] 3 [/SUP], Zachary Nuffer[SUP] 4 [/SUP]
Affiliations
Abstract
Coronavirus disease 2019 (COVID-19) is known to manifest with bilateral pneumonia and acute respiratory distress syndrome. This infection with severe acute respiratory syndrome coronavirus 2 (SAR-CoV-2) is alarming because it not only affects the respiratory system but may also cause thromboembolic events. Multiple studies have reported procoagulation/hypercoagulable complications in COVID-19. This case series is a valuable addition to the literature because it reflects unique presentations of thrombotic events in COVID-19 patients. We report two cases in which patients presented with thromboembolic complications secondary to COVID-19 infection: one with severe bowel ischemia and the other with blue toe syndrome. To formulate management strategies to prevent fatal outcomes for patients with COVID-19, physicians must be vigilant in identifying life-threatening thromboembolic complications from this disease.
Keywords: blue toe syndrome; bowel ischemia; covid-19; sars-cov-2; thromboembolic complications.
. 2022 Feb 26;14(2):e22637.
doi: 10.7759/cureus.22637. eCollection 2022 Feb.
Rare Thrombotic Complications of COVID-19: A Case Series
Sruthi Vellanki[SUP] 1 [/SUP], Anup Kumar Trikannad Ashwini Kumar[SUP] 1 [/SUP], Ryan Stoffel[SUP] 2 [/SUP], Sravya Vellanki[SUP] 3 [/SUP], Zachary Nuffer[SUP] 4 [/SUP]
Affiliations
- PMID: 35371674
- PMCID: PMC8959779
- DOI: 10.7759/cureus.22637
Abstract
Coronavirus disease 2019 (COVID-19) is known to manifest with bilateral pneumonia and acute respiratory distress syndrome. This infection with severe acute respiratory syndrome coronavirus 2 (SAR-CoV-2) is alarming because it not only affects the respiratory system but may also cause thromboembolic events. Multiple studies have reported procoagulation/hypercoagulable complications in COVID-19. This case series is a valuable addition to the literature because it reflects unique presentations of thrombotic events in COVID-19 patients. We report two cases in which patients presented with thromboembolic complications secondary to COVID-19 infection: one with severe bowel ischemia and the other with blue toe syndrome. To formulate management strategies to prevent fatal outcomes for patients with COVID-19, physicians must be vigilant in identifying life-threatening thromboembolic complications from this disease.
Keywords: blue toe syndrome; bowel ischemia; covid-19; sars-cov-2; thromboembolic complications.